Health Jefferies resumes GSK coverage at 'buy', sees 30% upside on oncology firepower By Ian Lyall 17/07
What brokers say British economy is tracking materially stronger than expected, says investment bank By Jamie Ashcroft 17/07
Retail & consumer Auto Trader Group target slashed as broker now sees little room to rerate By Jamie Ashcroft 17/07
Energy BP's big opportunity is in its upstream oil and gas business - analyst By Jamie Ashcroft 17/07
Retail & consumer American bank says Ryanair's share price weakness has run too far By Ian Lyall 17/07
Retail & consumer JP Morgan backs Auction Technology and YouGov, turns cautious on Auto Trader and Trainline By Ian Lyall 17/07
Retail & consumer Panmure Liberum upgrades Dunelm after respectable fourth quarter By Ian Lyall 17/07
Retail & consumer M&S shares could double as investment drive gathers pace, says Shore Cap By Oliver Haill 16/07
Health Citi starts Hikma at 'buy' with strategy reset offering compelling entry point By Ian Lyall 16/07
Retail & consumer B&M divides City analysts as hopes of a turnaround face fresh scrutiny By Oliver Haill 16/07
Finance Experian shares lead FTSE 100 fallers despite backing outlook after steady quarter - UPDATE By Oliver Haill 16/07
Battery Metals Century Lithium hits milestone as Angel Island lithium becomes battery-ready metal By Proactive 16/07
Retail & consumer Target traffic trends improve as merchandising reset gains momentum, says Jefferies By Emily Jarvie 15/07
Health Johnson & Johnson’s Spravato sales growth supports psychedelic drug opportunity: Jefferies By Emily Jarvie 15/07
